In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

VIDEOS

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...

We are excited to share with you a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology...

ARTICLES

From the Grace Archives | Originally Published November 12, 2014 | By Dr. Weiss | Leave a comment Smoking is the most common cause of lung cancer; 85%...
From the Grace Archives | Originally Published November 12, 2014 | By Dr. Weiss | Leave a comment Smoking is the most common cause of lung cancer; 85%...

What are Patient Reported Outcomes and why are they important to patients? Patient reported outcomes (PROs) can be thought of as any report or...

From the Grace Archives | Originally Published May 30, 2011 | By Dr West | 3 Comments In my last post, I described a recent piece in the NEJM that...
From the Grace Archives | Originally Published May 30, 2011 | By Dr West | 3 Comments In my last post, I described a recent piece in the NEJM that...

COMMUNITY FORUM

Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination...
Hi all, I have been reading posts on the forum and I apologise for my questions however I am very concerned. I am a 26 year old female smoker for a...
Hi CancerGrace Members, Grace has been asked to pass along this invitation by Tulane University's Psycho-Oncology Research Program whose Mission...
About 3 years ago a friend was massaging my back n I went to school for massage therapy so I know how to massage under the shoulder blades so I was...
Dear All good day, I am Serpil, ı have lung cancer (adenocarcinoma) sinse 2017. First year i used Tarceva and it helps to remove 60-70% of cancer...

Recent Comments

Hi Bob, Welcome to Grace.  I…
Comment By JanineT GRACE … on May 3, 2023 9:08 am
Thank you Janine.
Comment By szhang123 on Apr 24, 2023 6:37 pm
Please reach out with any more questions
Comment By Amy B on Apr 18, 2023 10:15 am
Hi Kimberly, Welcome to…
Comment By Amy B on Apr 18, 2023 10:15 am

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer Patients on Immunotherapy?

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss if taking a moderate to high dose of steroids will affect lung cancer patients on immunotherapy.  

ASCO 2018 Roundtable - Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and and Chemo

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and Chemotherapy.  

Mixed Results from Treatment

Has anyone had mixed results from chemo/immunotherapy?  My uncle was diagnosed with stage iv nsclc (exon 20 mutation).  It has spread to the bones, lymph nodes and adrenal glands.  He did 6 rounds of chemo with immunotherapy (alimta/keytruda/carbo) and then continued with keytruda/alimta.  We just received his first PET and brain MRI results since his initial diagnosis and while some of the cancer shrunk, some grew and there are new lesions not seen in April.

Videos now posted! OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?

On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for Metastatic Lung Cancer. We are pleased to be able to share with you the videos from the live webcast, available now.  View the videos here

Drs. Jack West, Vivek Mehta, Puneeth Iyengar, and Eric Vallieres discussed the following topics: 

~Newer Technologies in Radiation

Operations Director for GRACE. Have worked with cancerGRACE.org since July 2009.  Became involved as a caregiver to my best friend, and quickly came to see that GRACE is filling a need in the area of cancer education. 

OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?

Video

On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a discussion on Local Therapies for Metastatic Lung Cancer. We are pleased to share with you the videos from the live webcast.

 

Our faculty discussed the following topics: 

~Newer Technologies in Radiation

~Novel Indications for Local Therapy in Advanced NSCLC

~The Growing Potential Utility of Surgery in Advanced NSCLC

~Systemic Therapies for Advanced NSCLC

~Panel Discussion and Q&A


  

Lung Cancer Video Library - Immunotherapy in Stage lll NSCLC - The Pacific Trial and Imfinzi

Video

Dr. Karen Kelly, Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, met with GRACE to bring updates to our Lung Cancer Video Library.

In this video, Dr. Kelly discusses the role of immunotherapy in stage lll NSCLC, specifically the Pacific Trial and Imfinzi.


We thank the following organizations for their support  
Subscribe to In Treatment